Alexza Reports Fourth Quarter and Year End 2014 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/29/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- McKesson reports cybersecurity incident affecting its information systems
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- BioNTech ends colorectal cancer mRNA therapy trial early
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Needham sees mature node semiconductor strength in latest tracker
Alexza Pharma (ALXA) Tops Q4 EPS by 33c
March 9, 2015 4:18 PM EDTAlexza Pharma (NASDAQ: ALXA) reported Q4 EPS of ($0.35), $0.33 better than the analyst estimate of ($0.68). Revenue for the quarter came in at $1.45 billion, versus $1.3 million reported last year.
For earnings history and earnings-related data on Alexza Pharma (ALXA) click here.
... More